Am J Gastroenterol
- MOHAMED MFH, Marino D, Elfert K, Beran A, et al
Dye Chromoendoscopy Outperforms High-Definition White Light Endoscopy in
Dysplasia Detection for Patients With Inflammatory Bowel Disease: An Updated
Meta-Analysis of Randomized Controlled Trials.
Am J Gastroenterol. 2024;119:719-726.
BMC Gastroenterol
- WANG J, Tong S, Lu B
Influential factors on disease activity in Crohn's disease and their Roc curve
evaluation: a cross-sectional study.
BMC Gastroenterol. 2024;24:126.
Dig Dis Sci
- MOTWANI KK, Alizadeh M, Abutaleb A, Grossman J, et al
Correlation Between Serum and Fecal Biomarkers and Patient-Reported Outcomes in
Patients with Crohn's Disease and Ulcerative Colitis.
Dig Dis Sci. 2024 Apr 5. doi: 10.1007/s10620-024-08421.
- HARRIS S, Feagan BG, Hanauer S, Vermeire S, et al
Ozanimod Differentially Impacts Circulating Lymphocyte Subsets in Patients with
Moderately to Severely Active Crohn's Disease.
Dig Dis Sci. 2024 Apr 3. doi: 10.1007/s10620-024-08391.
- FIELD J, Shah ND, Memel Z, Mahadevan U, et al
Exclusive Yet Effective: The Crohn's Disease Exclusion Diet as Treatment for
Medication-Refractory Disease.
Dig Dis Sci. 2024 Mar 30. doi: 10.1007/s10620-024-08345.
Drugs
- SHIRLEY M
Etrasimod: First Approval.
Drugs. 2024;84:247-254.
Eur J Gastroenterol Hepatol
- FREEMAN HJ
Osteonecrosis (avascular necrosis) in inflammatory bowel disease: an
extraintestinal clinical feature, not caused by corticosteroids.
Eur J Gastroenterol Hepatol. 2024;36:503-504.
Gut
- GABRIELS RY, van der Waaij AM, Linssen MD, Dobosz M, et al
Fluorescently labelled vedolizumab to visualise drug distribution and mucosal
target cells in inflammatory bowel disease.
Gut. 2024 Apr 5:gutjnl-2023-331696. doi: 10.1136/gutjnl-2023-331696.
- KARMI N, Sun S, Festen EAM, Vich Vila A, et al
Gut microbial metabolism of 5-aminosalicylic acid in inflammatory bowel disease.
Gut. 2024 Apr 3:gutjnl-2024-332205. doi: 10.1136/gutjnl-2024-332205.
Inflamm Bowel Dis
- PIOVANI D, Armuzzi A, Bonovas S
Association of Depression With Incident Inflammatory Bowel Diseases: A Systematic
Review and Meta-Analysis.
Inflamm Bowel Dis. 2024;30:573-584.
- KHALAJI A, Babajani N, Amirsardari Z, Saeedian B, et al
Unveiling the Ghrelin and Obestatin Roles in Inflammatory Bowel Diseases: A
Systematic Review and Meta-Analysis Assessing Their Pathogenic Implications and
Biomarker Utility.
Inflamm Bowel Dis. 2024;30:629-640.
- BAJAJ A, Markandey M, Singh M, Sahu P, et al
Exclusive Enteral Nutrition Mediates Beneficial Gut Microbiome Enrichment in
Acute Severe Colitis.
Inflamm Bowel Dis. 2024;30:641-650.
- MAEDA K, Kawashima H
Reply: Interleukin-18 Inhibition in Inflammatory Bowel Diseases: A Delicate
Balance.
Inflamm Bowel Dis. 2024;30:695-696.
- UMAR N, Harvey P, Adderley NJ, Haroon S, et al
The Time to Inflammatory Bowel Disease Diagnosis for Patients Presenting with
Abdominal Symptoms in Primary Care and its Association with Emergency Hospital
Admissions and Surgery: A Retrospective Cohort Study.
Inflamm Bowel Dis. 2024 Apr 2:izae057. doi: 10.1093.
- MARK-CHRISTENSEN A, Kristiansen EB, Laurberg S, Erichsen R, et al
Prior Appendectomy Is Associated With a Milder Clinical Course in Crohn's
Disease: A Nationwide Population-based Cohort Study.
Inflamm Bowel Dis. 2024 Apr 2:izae059. doi: 10.1093.
- LIN ZH, Li CP, Sun CK, Cho DY, et al
Increased Risk of Inflammatory Bowel Disease Among Patients With Nontyphoidal
Salmonella Infections: A Population-Based Cohort Study.
Inflamm Bowel Dis. 2024 Apr 3:izae053. doi: 10.1093.
- LEITAO AMF, Gondim FAA
On the Risk of Neurological Disorders in Patients With Inflammatory Bowel
Disease.
Inflamm Bowel Dis. 2024 Apr 3:izae074. doi: 10.1093.
- ZAMANI M, Malekzadeh R
Reply: On the Risk of Neurological Disorders in Patients With Inflammatory Bowel
Disease.
Inflamm Bowel Dis. 2024 Apr 3:izae079. doi: 10.1093.
- ATIA O, Friss C, Focht G, Magen Rimon R, et al
Durability of the First Biologic in Children and Adults With Ulcerative Colitis:
A Nationwide Study from the epi-IIRN.
Inflamm Bowel Dis. 2024 Apr 5:izae067. doi: 10.1093.
J Crohns Colitis
- MERTZ NORGARD B, Garvik OS, Zegers FD, Nielsen J, et al
New surgery and hospital-diagnosed infections in elderly patients with
inflammatory bowel disease undergoing surgery - a nationwide cohort study.
J Crohns Colitis. 2024 Apr 5:jjae047. doi: 10.1093.
- VAN LINGEN E, Nooij S, Terveer E, Crossette E, et al
Fecal Microbiota Transplantation engraftment after budesonide or placebo in
patients with active ulcerative colitis using pre-selected donors: a randomized
pilot study.
J Crohns Colitis. 2024 Apr 4:jjae043. doi: 10.1093.
- KUMAR S, De Kock I, Blad W, Hare R, et al
Magnetic resonance enterography and intestinal ultrasound for the assessment and
monitoring of Crohn's disease.
J Crohns Colitis. 2024 Mar 30:jjae042. doi: 10.1093.
PLoS One
- SINCLAIR J, Brooks-Warburton J, Bottoms L
Perceptions, behaviours and barriers towards exercise practices in inflammatory
bowel disease.
PLoS One. 2024;19:e0299228.
- QUENEHERVE L, Trang-Poisson C, Fantou A, Flamant M, et al
Confocal laser endomicroscopy as predictive biomarker of clinical and endoscopic
efficacy of vedolizumab in ulcerative colitis: The DETECT study.
PLoS One. 2024;19:e0298313.
Scand J Gastroenterol
- LARSEN L, Olesen AE, Nayeb AB, Grontved S, et al
Beyond diagnosis: investigating hospital referral impact on biological treatment
initiation, hospital admission, and surgery patterns in inflammatory bowel
disease - a Danish population based study.
Scand J Gastroenterol. 2024 Apr 3:1-8. doi: 10.1080/00365521.2024.2337829.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016